MYGN Message Board - Msg: 2517524

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MYGN

MYGN 6.295

-3.0%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Benadam who wrote (2)	10/22/1997 2:20:00 PM
From: Frank Chen	Read Replies (1) of 29

To all, some information and thoughts, No clinical trial ongoing. Major revenue source is R&D collaboration with several big boys, plus the diagnosis kit for BRCA1/2 gene mutations (very small amount of revenue judging from the latest filing with SEC). But there're several other companies selling detection kits at lower price. Although MYGN's kit is a full-sequencing kit (more thorough and accurate), but the cost is higher, and the price is higher. Earning's out in mid-Nov. The financial arrangement looks like a 4000 contract bullish spread, I would like to see more details on that thing. The company will have to do lots of heavy lifting to pump up the stock price to get a $48/sh profit with those contracts. The stock will have to go above $50-60 for that to realize. Of course, it's just my guess, you need to see the detail on the statement. Regards FC

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next